Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Drug Utilization Study for Olodaterol

Trial Profile

Drug Utilization Study for Olodaterol

Completed
Phase of Trial: Phase IV

Latest Information Update: 25 Apr 2018

At a glance

  • Drugs Olodaterol (Primary) ; Indacaterol
  • Indications Chronic obstructive pulmonary disease
  • Focus Therapeutic Use
  • Sponsors Boehringer Ingelheim
  • Most Recent Events

    • 09 Apr 2018 Status changed from active, no longer recruiting to completed.
    • 02 Nov 2017 Status changed from recruiting to active, no longer recruiting.
    • 01 Mar 2017 Status changed from not yet recruiting to recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top